🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative findings that clarify how the body's defense network attacks dangerous pathogens while protecting the body's own cells.

Three esteemed researchers—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this honor.

Their research identified specialized "security guards" within the immune system that eliminate malfunctioning immune cells that could attacking the organism.

These findings are now paving the way for new treatments for immune disorders and cancer.

The laureates will divide a prize fund valued at 11 million Swedish kronor.

Decisive Findings

"Their work has been essential for comprehending how the immune system operates and why we don't all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

The team's studies address a fundamental mystery: How does the defense system protect us from numerous infections while leaving our own tissues intact?

The body's protection system uses white blood cells that search for signs of disease, including viruses and bacteria it has never encountered.

Such cells employ detectors—called recognition units—that are generated randomly in countless variations.

That gives the defense network the ability to combat a wide array of threats, but the unpredictability of the mechanism unavoidably produces white blood cells that may attack the host.

Security Guards of the Body

Scientists previously knew that some of these problematic defense cells were destroyed in the thymus—the site where white blood cells mature.

The latest award recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to disarm other defenders that attack the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "The findings have laid the foundation for a new field of investigation and accelerated the development of innovative therapies, for instance for tumors and autoimmune diseases."

In malignancies, T-regs block the body from fighting the tumor, so research are focused on lowering their quantity.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the body is no longer under attack. A comparable approach could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Experiments

Prof Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that injecting defense cells from other mice could prevent the illness—implying there was a system for blocking defenders from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in mice and humans that resulted in the identification of a gene critical for the way regulatory T-cells function.

"Their groundbreaking work has uncovered how the immune system is controlled by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"The research is a remarkable example of how basic biological study can have far-reaching implications for public health."